Legend Capital

Legend Capital, founded in 2001 as a subsidiary of Legend Holdings Ltd., is a prominent asset manager based in China. With a focus on private equity investments, the firm manages approximately $700 million across four funds and specializes in early-stage and mid-market growth ventures. Its investment strategy primarily targets high-growth companies with significant operations in China or related markets, particularly in sectors such as information technology, consumer goods, clean technology, healthcare, and equipment manufacturing. Legend Capital is known for its active involvement with portfolio companies, providing comprehensive business resources and tailored services to enhance business development and company visibility in the Chinese market. The firm’s portfolio includes notable companies like Joyo.com, SinoCom, and Solarfun Power, reflecting its commitment to driving innovation and value creation within China's venture capital landscape.

Raymond Chen

Co-chief Investment Officer

Arthur Ge

Managing Director

Frank Hong

Managing Director

Jenking Shao

Managing Director

Piau Voon Wang

Managing Director and Chief Operating Officer

Jafar Wang

Co-CIO / MD

Hank Zhou

Executive Director

377 past transactions

Bio-Engine

Series C in 2023
Bio-Engine engages in research and development of veterinary biological products. The company develops and manufactures antibodies, recombinant proteins, human and livestock virus vaccines through serum free suspension of animal cells. The company also provide clinical trial services for pharmaceutical manufacturers and scientific research units. The company was founded in 2014 and is headquartered in Shanghai, China.

ZStack

Series C in 2023
ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

Tianfu

Series C in 2022
Nanjing Tianfu Software Co., Ltd. develops custom software solutions for various industries, such as turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. The company founded in 2011 and is based in Nanjing, China.

ClinChoice昆翎

Series E in 2022
ClinChoice, also known as Fountain Medical Development Ltd, is a contract research organization based in Beijing, China. The company specializes in providing comprehensive, ICH GCP compliant clinical research services to multinational clients in both China and the United States. Its offerings include consulting, project management, regulatory affairs, and clinical operations, as well as central laboratory services. ClinChoice also focuses on site management, biometrics, and designing clinical trials. Additional services encompass the collection, review, assessment, and reporting of adverse events and serious adverse events, along with data and safety monitoring board handling and signal detection services. Founded in 2006, ClinChoice has established itself as a key player in the clinical research sector.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of integrated circuit automatic test equipment, specializing in solutions for semiconductor manufacturers. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an City, Shanghai, and Suwon, South Korea, the company offers a range of products including test boards, software solutions, and memory systems. TBSTest Technology also provides pre-sales and after-sales support for its equipment, accessories, and software systems, catering to clients in integrated circuit design and production, as well as scientific research institutions and educational organizations. The company is dedicated to advancing testing technology for ultra-large-scale integrated circuits, ensuring high-quality performance for enterprise users in the semiconductor industry.

Nest

Series A in 2022
Nest is a manufacturer of lab equipment made of plastic. Modern production tools are employed in a huge manufacturing facility. In order to offer their end users more affordable solutions and laboratory supplies, they continue to study and create new fundamental supplies suitable for life sciences research.

Tailan New Energy

Series A in 2022
Tailan New Energy is co-founded by lithium battery R&D experts introduced by the national high-level overseas talent project and a senior domestic industrialization team, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.

Senscomm Semiconductor

Series A in 2022
Senscomm Semiconductor Co., Ltd. is a fabless semiconductor company established in 2018 and headquartered in Suzhou, China. The company specializes in designing and developing advanced semiconductor products, having launched over 20 offerings that meet global demand. Its product portfolio primarily focuses on applications in augmented reality (AR), virtual reality (VR), the internet of things (IoT), and electric vehicles (EV). Senscomm aims to leverage innovation in these rapidly growing sectors to enhance connectivity and performance in modern technology.

FIT2CLOUD

Series D in 2022
Hangzhou Fit2Cloud Information Technology Co., Ltd., founded in 2014 and based in Beijing, China, operates a comprehensive cloud management platform designed to enhance the management of multi-cloud environments for enterprise customers. The platform includes features such as hybrid IT integration, a control center, self-service operations, resource and cost analysis, DevOps tools, and security audits. FIT2CLOUD serves various industries, including finance, manufacturing, media, energy, telecommunications, and the Internet. By addressing challenges related to IT operation security and continuous application delivery, FIT2CLOUD aims to facilitate smoother management and utilization of cloud services, ultimately supporting enterprises in their digital transformation journey.

ZHIYI TECH

Venture Round in 2022
Developer of an artificial intelligence technology designed to serve in clothing design. The company's AI platform provides integrated solutions to customize personal selection and fashion styles and helps designers capture and determine the popular clothing styles, enabling users to efficiently track the market trend of clothing styles and make better customized clothing products.

Reliable Med

Series A in 2022
Reliable Med is a medical device developer.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technology is a Chinese artificial intelligence (AI) chip maker

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

TuringQ

Seed Round in 2022
TuringQ, established in February 2021, specializes in the research and development of quantum information technology, particularly focusing on optical quantum chips and quantum computing. The company employs lithium niobate on insulator (LNOI) photonic chips and femtosecond laser direct writing techniques to create advanced photonic circuits. TuringQ has made significant advancements in areas such as photonic quantum chips, scientific research-grade photonic quantum computers, and photonic quantum measurement and control systems. Additionally, the company is developing photonic quantum EDA software and cloud platforms aimed at enhancing capabilities in quantum computing. TuringQ's innovations target applications in intelligent computing and power engines, positioning it as a leader in the emerging field of quantum technologies.

Inceptio Technology

Series B in 2022
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

GluBio Therapeutics

Series A in 2022
GluBio Pharmaceutical focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

Hoteam Software

Series C in 2022
Shandong Hoteam Software Co., Ltd, established in 1993 and based in Jinan, China, specializes in developing software products for the manufacturing sector. As a subsidiary of China Aerospace Science and Technology Corporation, the company focuses on providing industrial enterprises with comprehensive 3D-centric intelligent manufacturing solutions. Its software platforms encompass three-dimensional design, intelligent management, and visualization technologies, which aim to enhance work efficiency and reduce operational costs for clients engaged in collaborative research and development.

Zshield

Series C in 2022
ZShield Inc. provides cyberspace data security and big data business risk management. The company offers production innovation and data security services, information security platform, and AndunTM ZS-ISP which helps government and enterprises. The company was founded in 2014 and is based in Beijing, China.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Leapstack

Series C in 2021
Leapstack is an insurance technology company specializing in big data artificial intelligence technology. It is committed to building big data artificial intelligence solutions for commercial insurance companies and social security management agencies. The company was founded in February 2016 and has received angels from Gaochun Capital and Fumu Assets. It is headquartered in Shanghai and has offices in Beijing and Nanjing.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

River Security

Series C in 2021
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

TuringQ

Seed Round in 2021
TuringQ, established in February 2021, specializes in the research and development of quantum information technology, particularly focusing on optical quantum chips and quantum computing. The company employs lithium niobate on insulator (LNOI) photonic chips and femtosecond laser direct writing techniques to create advanced photonic circuits. TuringQ has made significant advancements in areas such as photonic quantum chips, scientific research-grade photonic quantum computers, and photonic quantum measurement and control systems. Additionally, the company is developing photonic quantum EDA software and cloud platforms aimed at enhancing capabilities in quantum computing. TuringQ's innovations target applications in intelligent computing and power engines, positioning it as a leader in the emerging field of quantum technologies.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization that provides research and development services in support of drug discovery. Its services include recombinant protein production; in vitro assays and screening; medicinal chemistry; structural biology; and target validation. The company was founded in 2009 and is based in Jiangyin, China. Wuxi Biortus Biosciences Co. Ltd. operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.

Wangdiantong

Series D in 2021
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

H.Extract

Series C in 2021
H.Extract, established in 2010 and based in Qingdao, China, specializes in producing natural extracts from various spices such as pepper, ginger, garlic, and cumin for the food manufacturing sector. The company focuses on the research and development of high-quality extracts to meet the needs of food producers, enhancing flavor and nutritional value in their products. H.Extract is committed to maintaining industry standards and ensuring customer satisfaction through its innovative solutions and dedication to quality. With a growing reputation in the market, the company continues to expand its product offerings and strengthen its position within the food industry.

HC Scientific

Series B in 2021
HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

Mathpresso, Inc.

Series C in 2021
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Horizon Robotics

Series C in 2021
Beijing Horizon Robotics Technology Co., Ltd. develops chips for robots. The company was founded in 2015 and is based in China.

Bruco Group

Series B in 2021
Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Reliable Med

Series A in 2021
Reliable Med is a medical device developer.

Fiture

Series B in 2021
Fiture, a fitness technology company, is redefining the home fitness scenarios through intelligent hardware and AI-empowered fitness content.

StoneWise

Series B in 2021
Beijing StoneWise Technology Co., Ltd. operates as a technology company that engages in the research and development (R&D) of artificial intelligence-driven drug design solutions for drug R&D enterprises and institutions. Its drug discovery platform focuses on the investigation and repurpose of nucleoside-based RNA polymerase inhibitors and their potential use in COVID-19 infection treatment. The company was founded in 2018 and is based in Beijing, China.

Kunlun

Venture Round in 2021
Kunlun is an artificial intelligence chip designer and manufacturer.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. develops and sells protein/peptide drugs for treating diseases in multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy/macular edema, and neuro-degenerative diseases. The company was founded in 2017 and is based in Hangzhou, China.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Jifan Biotechnology

Series A in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

MicuRx Pharmaceuticals

Series E in 2020
MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available in China. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.

Wangdiantong

Series C in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

Bruco Group

Series A in 2020
Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

GalaxySpace

Series C in 2020
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

LYNK Pharmaceuticals

Series A in 2020
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Aqrose Technology

Series B in 2020
Beijing Aqrose Technology Co., Ltd. is a high-tech company specializing in the research and development of computer vision and robotic technology for industrial automation. Founded in 2017, the company is based in Beijing, China, and leverages artificial intelligence to enhance manufacturing processes. Aqrose Technology offers a range of products, including an artificial intelligence deep learning visual inspection platform known as AIDI, which addresses industrial challenges such as defect detection and classification. The company also provides intelligent robots, like AIPICK, equipped with 3D vision technology and AI-based defect inspection systems. With a founding team originating from the Artificial Intelligence Laboratory of Tsinghua University, Aqrose Technology is committed to advancing industrial automation through innovative machine vision and machine learning solutions, thereby empowering advanced manufacturing and smart logistics sectors in China.

Genskey

Series C in 2020
GensKey is a genetic testing medical diagnostic service provider that applies high-throughput sequencing technology to pathogen diagnosis to solve a series of difficulties in the detection rate, timeliness and accuracy of pathogenic diagnosis, so that many patients with severe infections get timely and accurate. Diagnosis.
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

Delova Biotech

Venture Round in 2020
Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States.

LEADRIVE

Series B in 2020
Leadrive Technology (Shanghai) Co.,Ltd. manufactures homebred power modules and electric vehicle solutions. The company offers products, such as Power Module, Power Control Unit, and Motor. Leadrive Technology (Shanghai) Co.,Ltd. was founded in 2017 and is based in Shanghai, China with additional offices in Shanghai, China; and Aachen, Germany.

Haihe Biopharma

Series B in 2020
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Tongcheng Shenghuo

Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Uditech

Series B in 2020
Shenzhen Uditech Co., Ltd. develops and manufactures robots for service industry, including restaurants, television, and hospitals. It also manufactures quad core processors. Its robots comprise features, such as face recognition, obstacle avoidance, multi-machine cycle operation, food order and delivery, smart voice, and item transportation. The company was founded in 2013 and is based in Shenzhen, China.

iBeiDiao

Series B in 2020
iBeiDiao is a SaaS background check platform that combines with the Internet.

Novast

Venture Round in 2020
Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.

Wangdiantong

Series B in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

Qingju

Venture Round in 2020
Qingju is a bike sharing company.

ANYCOLOR

Post in 2020
Ichikara Inc. is an entertainment start-up based in Tokyo, Japan, founded in 2017. The company specializes in creator support and licensing, primarily focusing on the management and operation of virtual streamers associated with the "Nijisanji Project." Ichikara offers a range of services, including access to distribution studios, advertising partnerships, event coordination, and opportunities for program appearances. Additionally, the company actively seeks to discover new talent through auditions, aiming to enhance the virtual entertainment landscape. By leveraging advanced technology, Ichikara strives to create engaging experiences that resonate with audiences globally.

Harbour Biomed

Series B in 2020
Harbour Biomed is a biotechnology company focused on developing bio-therapeutics for immuno-oncology and inflammatory diseases. Established in 2016 and headquartered in Shanghai, with additional operations in Cambridge, Massachusetts, and Rotterdam, the company utilizes two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain-only bispecific antibodies. These platforms facilitate the creation of innovative therapeutic antibodies, enhancing drug discovery and development processes. Harbour Biomed is actively involved in the development of several candidates, including Batoclimab for autoimmune diseases and Tanfanercept for dry eye disease. The company also collaborates with various institutions and partners to license its antibody platforms, further expanding its reach in the biotechnology sector.

Feiyu

Series A in 2020
Shanghai Feiyu Network Technology Co., Ltd. operates a luxury products trading platform. It sells bags, accessories, watches, footwear, and clothes. The company is based in Shanghai, China.

JenaValve Technology

Series D in 2020
JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

Genskey

Series B in 2020
GensKey is a genetic testing medical diagnostic service provider that applies high-throughput sequencing technology to pathogen diagnosis to solve a series of difficulties in the detection rate, timeliness and accuracy of pathogenic diagnosis, so that many patients with severe infections get timely and accurate. Diagnosis.

Lunit

Series C in 2020
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

Nanovision Technology

Series B in 2019
Nanovision Technology is located in Zhongguancun Yongfeng high-tech industrial base, with thousands of square meters of R&D foundation in Yonyou Industrial Park. We also set up a subsidiary company in Chengdu. their company is a high-tech enterprise focused on high-speed and high-precision radiology imaging.Nanovison focus in static CT,x-ray CMOS detectors and x-ray imaging software, etc.Which can be widely used in medical, industrial, security and other fields.

Dongfang Weiyin

Series C in 2019
Dongfang Weiyin is a financial service platform focused on small and micro enterprises. Established in 2015 and headquartered in Beijing, China, the company specializes in developing DFWYBANK.com, an accounting and tax database solution tailored for banks, tax bureaus, and small to medium-sized businesses. Through its services, Dongfang Weiyin aims to enhance financial management and compliance for its clients, contributing to the growth and sustainability of smaller enterprises in the Chinese market.

Suzhou Ribo Life Science

Series C in 2019
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.

RT-Thread

Series B in 2019
RT-Thread develops an open source real-time operating system for embedded devices. The company offers an autonomous Internet of Things operating system with features, such as cross-chip platform, real-time operating system kernel, cloud integration, ultra-low power design, quick start, security design, intelligent AI engine, and open platform, stable and reliable, rich components, easy to use, and scalable. Its integrated design of the device and cloud enables easy access to all major IoT device cloud platforms. The company’s system also offers functions, such as device virtual file system, device manager framework, low-power management framework, protocol stack, audio streaming framework, firmware remote upgrade FOTA, and third-party components. It serves new energy, electricity, consumption, home appliances, and transportation industries. The company was founded in 2006 and is based in Shanghai, China.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

dMed

Series B in 2019
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd manufacturers pet food. Its Products categories includes: pet treats series which made of chicken jerky, duck jerky, pork, lamb and fish, wet pet food with ingredient of meat and fruits and vegetables, and dog food with nutritional supplements, natural ingredients. It ships products to Europe, Asia, North America. Gambol Pet Group Co., Ltd was founded in 2006 and is headquartered in Liaocheng City, China.

Mathpresso, Inc.

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Mancando

Series A in 2019
Mancando is an automotive parts supplier company that provides car wearing parts for auto repair factory. They are an innovative model of traditional auto parts management, internet, and platform management. The company was founded in August 2015 and is based in Guangzhou, Guangdong, China.

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

GKHT Medical Technology

Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd. was established in February 2013 and is affiliated to Oriental Science and Technology Holding Group Co., Ltd. (hereinafter referred to as “Oriental Instrument”), a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. It is headquartered in Yizhuang Economic and Technological Development Zone, Beijing. . Since the establishment of Guoke Hengtai for 4 years, the company has experienced two rounds of investment in A and B, and its performance has continued to grow at a high speed, with a compound annual growth rate of over 50%. In 2017, the company officially launched the IPO listing journey.

AgotoZ

Series B in 2019
AgotoZ Technology provides a network transmission intelligent platform with the capabilities of resource calculation and security defense. Established in 2017, Guanmai Technology (Beijing) Co., Ltd. is a leading WAN high-speed transmission core technology, big data computing technology, security defense technology, and accelerates its core technologies and products through independent research and development, focusing on providing high-speed and efficient enterprises. Interoperability platform and related solutions.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Nanjing Inossem Software Technology Co., Ltd. provides enterprise application product development and consulting services. The company offers enterprise consulting services that include IT planning, supply chain consulting, ERP consulting, etc. It also focus on material management field of enterprises, and develops intelligent storage (Instock) and intelligent master data (Indata) based on the technical foundation of AI and IoT. The company was founded in 2015 and is based in Nanjing, China. It has additional offices in Canada, the United Kingdom, China, and Hong Kong.

Yungehuo

Series A in 2019
Yungehuo is a Logistics company.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service enterprises that provides overall ingredients supply chain solutions services. It has a nationwide modern cold chain logistics center, food processing plants, and other bases. Bohai has been recognized by the industry authorities and customers, has become the benchmark enterprises in the field of supply chain. Founded in June 2011, the company is headquartered in Beijing, China.

Jiangrongxin Technology

Series B in 2019
Developer of financial and marketing software for consumer financial services enterprises. The company's credit card core system helps card issuers manage cardholder's credit and incentives, while their marketing platform can make purchase recommendations to consumers and track user retention.

Bondent Technology

Series D in 2019
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

River Security

Series B in 2019
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Zongmu

Series C in 2019
ZongMu Technology was founded in January 2013. Headquartered in Pudong ZhangJiang high-tech park of Shanghai, ZongMu has RD centers in Beijing and ShenZhen respectively. Through its innovative solution and excellent service to the local market, ZongMu has shipped multiple SurroundView ADAS (Advanced Driving Assistance System) in main stream OEM automotive markets, becoming the leading SurroundView ADAS solution vendor for China domestic market and formed strategic partnership with multiple OEM car makers and their tier1 suppliers.

Hujing Tiaoyue

Series A in 2019
Beijing Hujing Tiaoyue Technology Co., Ltd. provides artificial intelligence (AI) sales solutions based on WeChat marketing scenarios. Its AI technology automatically filters the intended users, and provides sales ideas navigation and speech reminders in real time to improve sales efficiency and conversion rate. The company was founded in 2017 and is based in Beijing, China.

Zhenkunhang

Series D in 2019
Zhenkunhang, also known as Qingdao Zhenkun Trading, is an e-commerce platform for industrial products, including maintenance, operation, and repair (MRO) products. Zhenkunhang was founded in 1996. Qingdao Zhenkun Trading is a professional lubricant, adhesive, fasteners, and related equipment suppliers, is committed to providing customers with a full range of bonding and sealing, lubrication, fastening solutions. We work with a number of internationally renowned brands to creatively combine different suppliers and our own unique technologies and products to provide our customers with the most suitable solutions. Fastener products cover all types of fasteners in the world today, mainly including: hexagon socket head cap screws, hexagonal screws, stop screws (top screws), various mechanism screws, self tapping screws, nuts, various washers, Rivets, pins, splines, tools for the above products, nylon lock (tie), etc., and we offer products of different materials (carbon steel, stainless steel, copper, aluminum) We can provide DIN, ISO, NFE, JIS, ANSI, BS, GB different brand and non-brand fasteners according to your requirements.

Deepwise

Series C in 2019
Shenzhen Rui Medica is an artificial intelligence technology-based clinical imaging services provider. The company focuses on the development of clinical imaging diagnosis system for early-stage detection of cancer. Its services covers breast cancer, prostate cancer, and chest radiograph.